ArticleInternational journal of hematology2020

Successful management of hemodialysis-dependent refractory myeloma with modified daratumumab, bortezomib and dexamethasone regimen.

Shinichi Mizuno et al.PubMed ↗Publisher ↗

No numbers read from the abstract.